Last reviewed · How we verify

NCT07438288: SoLiDaRity

Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis

Recruiting now Last updated 27 February 2026
What this trial tests

trial testing Observation in Cirrhosis and Chronic Liver Disease in 2,200 participants. Currently enrolling.

Timeline
12 August 2022
Primary endpoint
12 August 2027
12 August 2032

Quick facts

Lead sponsorSingapore General Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,200
Start date12 August 2022
Primary completion12 August 2027
Estimated completion12 August 2032
Sites3 locations across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Singapore General Hospital

Who can join

18 and older, any sex, with Cirrhosis and Chronic Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients with liver cirrhosis. Clinical data will be retrieved from existing hospital records. This information may help doctors to identify patients with cirrhosis who are at risk of deterioration earlier (before they develop complications) and to develop effective treatment strategies to prevent or delay these complications. This study is designed as a prospective, non-interventional, observational study. This means that if you agree to participate in the study, you will not be required to undergo any additional hospital visits, tests, procedures or interventions other than the usual standard-of-care management that your doctor will provide. If you consent to participate in this study, you will be providing the study investigators permission to review and analyse your clinical data from the hospital clinical records. Your data will be collected throughout the course of your disease until liver transplantation or death.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observation

Trials testing the same drug.

Other recruiting trials for Cirrhosis and Chronic Liver Disease

Currently open trials in the same condition.

Other Singapore General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07438288.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing